CLINICAL_TRIALS
withdrawal
· 2014-12-12
Clinical Trial Update: Posaconazole as Salvage Therapy for Aspergillus Pulmonary Infection. [Phase 4]
Summary
A Phase 4 trial evaluating posaconazole as salvage therapy for pulmonary aspergillosis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taichung Veterans General Hospital | Conditions: Clinical Infection | Phase 4 | Status: WITHDRAWN